Showing results (1661-1670 of 1,967) with videos related to
Sort By:
Pageof 197
Blood|June 25, 2026
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative NeoplasmsFan He, Shuyang Lin, Tim Kong, et al.Plos One|April 19, 2013
Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndromeSusan M Gribble, Frances K Wiseman, Stephen Clayton, et al.Nucleic Acids Research|June 2, 2020
FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retentionJack Humphrey, Nicol Birsa, Carmelo Milioto, et al.Neurobiology of Aging|March 1, 2016
Imaging the accumulation and suppression of tau pathology using multiparametric MRIHolly E Holmes, Niall Colgan, Ozama Ismail, et al.Nature Communications|June 9, 2021
Maternal iron deficiency perturbs embryonic cardiovascular development in miceJacinta I Kalisch-Smith, Nikita Ved, Dorota Szumska, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2024
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaFrancine M Foss, Youn H Kim, H Miles Prince, et al.Blood Advances|January 1, 2024
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLLInhye E Ahn, Danielle M Brander, Yue Ren, et al.Blood|June 15, 2023
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphomaMwanasha H Merrill, Parastoo B Dahi, Robert A Redd, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk DiseaseMatthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.Angiology|August 26, 2000
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European StudyG Belcaro, A N Nicolaides, G Cipollone, et al.Pageof 197